You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Partial Manual Exchange Reduces Iron Accumulation During Chronic Red Cell Transfusions for Sickle Cell Disease

Savage, William J. MD, PhD; Reddoch, Shirley MD; Wolfe, Jaime MD; Casella, James F. MD

Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e31829d470d
Original Articles
Abstract

Iron overload is an inevitable consequence of chronic red cell transfusions without erythrocytapheresis or chelation therapy. The effectiveness of partial manual exchange, a technique used to slow iron loading, has not been evaluated. We evaluated all children with sickle cell disease (SCD) receiving chronic transfusion to identify chelation-naive subjects who had quantitative liver iron concentration (LIC) studies. Seventeen chelation-naive children with SCD received a median of 29 transfusions before first LIC determination. Serum ferritin concentrations were assessed before each transfusion. The mean volume of blood phlebotomized before each transfusion was 5.1±1.8 mL/kg, which cumulatively resulted in a calculated median of 35.0 mg/kg iron removal. Using linear regression, pretransfusion phlebotomy resulted in a statistically significant reduction in ferritin (−8.8 ng/mL of ferritin for each mg/kg of iron phlebotomized, P=0.02). A reduction in LIC from pretransfusion phlebotomy could not be established (P=0.4). Partial manual exchanges appear to be an effective strategy for slowing the pace of iron loading in the setting of chronic transfusion for SCD.

Author Information

*Division of Transfusion Medicine, Brigham and Women’s Hospital, Boston, MA

Division of Pediatric Hematology, Johns Hopkins University School of Medicine, Baltimore, MD

Division of Pediatric Gastroenterology, Children’s National Medical Center, Washington, DC

Supported in part by the Basic and Translational Research Program in Sickle Cell Disease, NIH U54HL090515 (W.J.S., J.F.C.) 5K12HL087169 (W.J.S., J.F.C.) and an American Society of Hematology Scholar Award (W.J.S.).

The authors declare no conflict of interest.

Reprints: William J. Savage, MD, PhD, Division of Transfusion Medicine, Brigham and Women’s Hospital, Amory 260, 75 Francis St., Boston, MA 02115 (e-mail: wjsavage@partners.org).

Received September 26, 2012

Accepted April 3, 2013

Copyright © 2013 Wolters Kluwer Health, Inc. All rights reserved.